Practicing medicine for more than three decades in the field of Obstetrics and Gynecology and Gynecologic Oncology, Dr. Matthew Boente MD is also an academician and consultant. His most recent post was as Medical Director for U.S. Medical Affairs, Gynecologic Oncology at Genentech Inc. in San Francisco. Dr. Boente led a large global cross-functional team responsible for the FDA approval of bevacizumab with chemotherapy in front line ovarian cancer.